Cargando…

Current models, challenges and best practices for work conducted between European academic cooperative groups and industry

BACKGROUND: The academia-industry interface is important, and, despite challenges that inevitably occur, bears the potential for positive synergies to emerge. Perceived barriers to wider collaboration in academia-industry oncology research in Europe need to be addressed, current academic cooperative...

Descripción completa

Detalles Bibliográficos
Autores principales: Stahel, Rolf A, Lacombe, Denis, Cardoso, Fatima, Casali, Paolo G, Negrouk, Anastassia, Marais, Richard, Hiltbrunner, Anita, Vyas, Malvika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103800/
https://www.ncbi.nlm.nih.gov/pubmed/32213534
http://dx.doi.org/10.1136/esmoopen-2019-000628
_version_ 1783512114483167232
author Stahel, Rolf A
Lacombe, Denis
Cardoso, Fatima
Casali, Paolo G
Negrouk, Anastassia
Marais, Richard
Hiltbrunner, Anita
Vyas, Malvika
author_facet Stahel, Rolf A
Lacombe, Denis
Cardoso, Fatima
Casali, Paolo G
Negrouk, Anastassia
Marais, Richard
Hiltbrunner, Anita
Vyas, Malvika
author_sort Stahel, Rolf A
collection PubMed
description BACKGROUND: The academia-industry interface is important, and, despite challenges that inevitably occur, bears the potential for positive synergies to emerge. Perceived barriers to wider collaboration in academia-industry oncology research in Europe need to be addressed, current academic cooperative group and industry models for collaboration need to be discussed, and a common terminology to facilitate understanding of both sectors’ concerns needs to be established with an eye towards improving academia-industry partnerships on clinical trials for the benefit of patients with cancer. METHODOLOGY: CAREFOR (Clinical Academic Cancer Research Forum), a multi-stakeholder platform formed to improve the direction for academic clinical trials in the field of oncology in Europe, formed the CAREFOR-Industry Working Group comprised of experienced professionals from European academic cooperative groups joined by industry representatives selected based on their activities in the area of medical oncology. They jointly discussed academic cooperative groups, clinical trials conducted between academic cooperative groups and industry, examples of successful collaborative models, common legal negotiation points in clinical trial contracts, data access, and principles of interaction. RESULTS: Four principles of interaction between the academia and industry are proposed: (1) clarify the roles and responsibilities of all partners involved in the study, (2) involve legal teams from an early stage; (3) acknowledge that data is an important output of the study, (4) agree on the intent of the trial prior to its start. CONCLUSIONS: The CAREFOR-Industry Working Group describes current models, challenges, and effective strategies for academia-industry research in Europe with an eye towards improving academia-industry partnerships on clinical trials for patients with cancer. Current perceived challenges are explained, and future opportunities/recommendations for improvement are described for the areas of most significant impact. Challenges are addressed from both the academic and industry perspectives, and principles of interaction for the optimal alignment between academia and industry in selected areas are proposed.
format Online
Article
Text
id pubmed-7103800
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-71038002020-03-31 Current models, challenges and best practices for work conducted between European academic cooperative groups and industry Stahel, Rolf A Lacombe, Denis Cardoso, Fatima Casali, Paolo G Negrouk, Anastassia Marais, Richard Hiltbrunner, Anita Vyas, Malvika ESMO Open Original Research BACKGROUND: The academia-industry interface is important, and, despite challenges that inevitably occur, bears the potential for positive synergies to emerge. Perceived barriers to wider collaboration in academia-industry oncology research in Europe need to be addressed, current academic cooperative group and industry models for collaboration need to be discussed, and a common terminology to facilitate understanding of both sectors’ concerns needs to be established with an eye towards improving academia-industry partnerships on clinical trials for the benefit of patients with cancer. METHODOLOGY: CAREFOR (Clinical Academic Cancer Research Forum), a multi-stakeholder platform formed to improve the direction for academic clinical trials in the field of oncology in Europe, formed the CAREFOR-Industry Working Group comprised of experienced professionals from European academic cooperative groups joined by industry representatives selected based on their activities in the area of medical oncology. They jointly discussed academic cooperative groups, clinical trials conducted between academic cooperative groups and industry, examples of successful collaborative models, common legal negotiation points in clinical trial contracts, data access, and principles of interaction. RESULTS: Four principles of interaction between the academia and industry are proposed: (1) clarify the roles and responsibilities of all partners involved in the study, (2) involve legal teams from an early stage; (3) acknowledge that data is an important output of the study, (4) agree on the intent of the trial prior to its start. CONCLUSIONS: The CAREFOR-Industry Working Group describes current models, challenges, and effective strategies for academia-industry research in Europe with an eye towards improving academia-industry partnerships on clinical trials for patients with cancer. Current perceived challenges are explained, and future opportunities/recommendations for improvement are described for the areas of most significant impact. Challenges are addressed from both the academic and industry perspectives, and principles of interaction for the optimal alignment between academia and industry in selected areas are proposed. BMJ Publishing Group 2020-03-25 /pmc/articles/PMC7103800/ /pubmed/32213534 http://dx.doi.org/10.1136/esmoopen-2019-000628 Text en © Author (s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, any changes made are indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Original Research
Stahel, Rolf A
Lacombe, Denis
Cardoso, Fatima
Casali, Paolo G
Negrouk, Anastassia
Marais, Richard
Hiltbrunner, Anita
Vyas, Malvika
Current models, challenges and best practices for work conducted between European academic cooperative groups and industry
title Current models, challenges and best practices for work conducted between European academic cooperative groups and industry
title_full Current models, challenges and best practices for work conducted between European academic cooperative groups and industry
title_fullStr Current models, challenges and best practices for work conducted between European academic cooperative groups and industry
title_full_unstemmed Current models, challenges and best practices for work conducted between European academic cooperative groups and industry
title_short Current models, challenges and best practices for work conducted between European academic cooperative groups and industry
title_sort current models, challenges and best practices for work conducted between european academic cooperative groups and industry
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103800/
https://www.ncbi.nlm.nih.gov/pubmed/32213534
http://dx.doi.org/10.1136/esmoopen-2019-000628
work_keys_str_mv AT stahelrolfa currentmodelschallengesandbestpracticesforworkconductedbetweeneuropeanacademiccooperativegroupsandindustry
AT lacombedenis currentmodelschallengesandbestpracticesforworkconductedbetweeneuropeanacademiccooperativegroupsandindustry
AT cardosofatima currentmodelschallengesandbestpracticesforworkconductedbetweeneuropeanacademiccooperativegroupsandindustry
AT casalipaolog currentmodelschallengesandbestpracticesforworkconductedbetweeneuropeanacademiccooperativegroupsandindustry
AT negroukanastassia currentmodelschallengesandbestpracticesforworkconductedbetweeneuropeanacademiccooperativegroupsandindustry
AT maraisrichard currentmodelschallengesandbestpracticesforworkconductedbetweeneuropeanacademiccooperativegroupsandindustry
AT hiltbrunneranita currentmodelschallengesandbestpracticesforworkconductedbetweeneuropeanacademiccooperativegroupsandindustry
AT vyasmalvika currentmodelschallengesandbestpracticesforworkconductedbetweeneuropeanacademiccooperativegroupsandindustry
AT currentmodelschallengesandbestpracticesforworkconductedbetweeneuropeanacademiccooperativegroupsandindustry